Health
NAFDAC Reinforces Prohibition on Multi-Dose Anti-Malaria Suspensions
The National Agency for Food and Drug Administration and Control (NAFDAC) has reiterated its ban on the registration of multi-dose artemether/lumefantrine dry powder for oral suspension, citing concerns over its stability and efficacy post-reconstitution.